Performance of albumin-bilirubin score in prediction of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding

Springer Science and Business Media LLC - Tập 11 Số 1 - 2021
Rehab Elsayed Elsafty1, Abdallah Ahmed Elsawy1, Ahmed Fawzy Selim1, Atef Taha1
1Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

Tóm tắt

Abstract Background Hepatic encephalopathy exacerbates the morbidity, delays hospital discharge, and increases the rate of readmissions of cirrhotic patients, particularly those are admitted by acute variceal bleeding. We evaluated the performance of albumin-bilirubin score in prediction of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding, in comparison to Child-Pugh and MELD scores. This prospective cohort study was conducted on 250 cirrhotic patients who were consecutively presented by acute variceal bleeding in the period from January to December 2020 at Tanta university emergency hospital. Albumin-bilirubin, Child-Pugh, and MELD scores were measured at admission, and then all patients were followed up for 4 weeks after endoscopic bleeding control for possible occurrence of hepatic encephalopathy Results Albumin-bilirubin, Child-Pugh, and MELD scores had significant performances in prediction of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding; in this regard, albumin-bilirubin score had the highest accuracy (AUC 0.858, CI 0.802-0.914, sig 0.000) followed by Child-Pugh score (AUC 0.654, CI 0.574–0.735, sig 0.001) and then MELD score (AUC 0.602, CI 0.519–0.686, sig 0.031). The cumulative incidence of hepatic encephalopathy in cirrhotic patients with albumin-bilirubin grade 3 was found to be significantly more than that present in albumin-bilirubin grade 2; most of these hepatic encephalopathy cases occurred in the first 2 weeks of follow-up period. Conclusions Albumin-bilirubin score has a significant performance in risk prediction of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding better than Child-Pugh and MELD scores. Albumin-bilirubin grades could be used as a risk stratifying tool to triage cirrhotic patients who will benefit from early discharge after bleeding control and those patients who will benefit from prophylactic measures for hepatic encephalopathy.

Từ khóa


Tài liệu tham khảo

American Association for the Study of Liver Diseases; European Association for the Study of the Liver (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol 61(3):642–659

Bleibel W, Al-Osaimi AM (2012) Hepatic encephalopathy. Saudi J Gastroenterol 18(5):301–309. https://doi.org/10.4103/1319-3767.101123

Patidar KR, Bajaj JS (2015) Covert and overt hepatic encephalopathy: diagnosis and management. Clin Gastroenterol Hepatol 13(12):2048–2061. https://doi.org/10.1016/j.cgh.2015.06.039

Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS (2012) Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 107(2):247–252. https://doi.org/10.1038/ajg.2011.314

Seraj SM, Campbell EJ, Argyropoulos SK, Wegermann K, Chung RT, Richter JM (2017) Hospital readmissions in decompensated cirrhotics: factors pointing toward a prevention strategy. World J Gastroenterol 23(37):6868–6876. https://doi.org/10.3748/wjg.v23.i37.6868

Del Piccolo F, Sacerdoti D, Amodio P, Bombonato G, Bolognesi M, Mapelli D et al (2003) Central nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion. Metab Brain Dis 18(1):51–62. https://doi.org/10.1023/A:1021930702815

Pugh R, Murray-lyon I, Dawson J (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649. https://doi.org/10.1002/bjs.1800600817

Wang YY, Zhao XH, Ma L, Ye JZ, Wu FX, Tang J, You XM, Xiang BD, Li LQ (2018) Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma. J Surg Oncol 118(3):440–445. https://doi.org/10.1002/jso.25184

Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A, Palmer D, Yeo W, Mo F, Lai P, Iñarrairaegui M, Chan SL, Sangro B, Miksad R, Tada T, Kumada T, Toyoda H (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33(6):550–558. https://doi.org/10.1200/JCO.2014.57.9151

Hiraoka A, Kumada T, Michitaka K, Kudo M (2019) Newly proposed ALBI grade and ALBI-T score as tools for assessment of hepatic function and prognosis in hepatocellular carcinoma patients. Liver Cancer 8(5):312–325. https://doi.org/10.1159/000494844

Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, Ma L, Qi LN, Ou BN, Li LQ (2016) Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg 103(6):725–734. https://doi.org/10.1002/bjs.10095

Toyoda H, Lai PB, O'Beirne J, Chong CC, Berhane S, Reeves H et al (2016) Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer 114(7):744–750. https://doi.org/10.1038/bjc.2016.33

Hiraoka A, Kumada T, Nouso K, Tsuji K, Itobayashi E, Hirooka M, Kariyama K, Ishikawa T, Tada T, Toyoda H, Kawasaki H, Hiasa Y, Michitaka K (2016) Proposed new sub-grouping for intermediate-stage hepatocellular carcinoma using albumin-bilirubin grade. Oncology. 91(3):153–161. https://doi.org/10.1159/000447061

Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative (2014) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg 12(12):1500–1524. https://doi.org/10.1016/j.ijsu.2014.07.014

Rattanasupar A, Tiawijit N, Rachatapantanakorn B (2014) Predictive factor for hepatic encephalopathy in cirrhotic patients who presented with acute variceal bleeding. J Med Assoc Thail 97(6):567–573

Kumar AS, Sibia RS (2015) Predictors of in-hospital mortality among patients presenting with variceal gastrointestinal bleeding. Saudi J Gastroenterol 21(1):43–46. https://doi.org/10.4103/1319-3767.151226

Wen J, Liu Q, Song J, Tong M, Peng L, Liang H (2013) Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. Digestion. 87(2):132–138. https://doi.org/10.1159/000346083

Fouad TR, Abdelsameea E, Abdel-Razek W, Attia A, Mohamed A, Metwally K, Naguib M, Waked I (2019) Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: post-therapeutic outcome and prognostic indicators. J Gastroenterol Hepatol 34(9):1604–1610. https://doi.org/10.1111/jgh.14659

Sharma P, Agrawal A, Sharma BC, Sarin SK (2011) Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol 26(6):996–1003. https://doi.org/10.1111/j.1440-1746.2010.06596.x

Higuera-de-la-Tijera F, Servín-Caamaño AI, Salas-Gordillo F, Pérez-Hernández JL, Abdo-Francis JM, Camacho-Aguilera J et al (2018) Primary prophylaxis to prevent the development of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding. Can J Gastroenterol Hepatol 2018:3015891

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 11 Số 1

Thông tin tác giả